Loss of heterozygosity of nucleotide excision repair factors in sporadic ovarian, colon and lung carcinomas: implication for their roles of carcinogenesis in human solid tumors.

[1]  A S Whittemore,et al.  Ovarian carcinoma in situ with germline BRCA1 mutation and loss of heterozygosity at BRCA1 and TP53. , 2000, Journal of the National Cancer Institute.

[2]  A. Huvos,et al.  Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancers. , 2000, Carcinogenesis.

[3]  Yian Ma,et al.  Absence of evidence for allelic loss or allelic gain for ERCC1 or for XPD in human ovarian cancer cells and tissues. , 2000, Cancer letters.

[4]  A. Sarasin,et al.  RETRACTED: Transcription-Coupled Repair of 8-oxoGuanine Requirement for XPG, TFIIH, and CSB and Implications for Cockayne Syndrome , 2000, Cell.

[5]  T. Lindahl,et al.  Quality control by DNA repair. , 1999, Science.

[6]  H. Frierson,et al.  Three distinct regions of allelic loss at 13q14, 13q21‐22, and 13q33 in prostate cancer , 1999, Genes, chromosomes & cancer.

[7]  C. Croce,et al.  Role of FHIT in Human Cancer , 1999 .

[8]  W. de Laat,et al.  Molecular mechanism of nucleotide excision repair. , 1999, Genes & development.

[9]  H. van Steeg,et al.  Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. , 1999, Molecular medicine today.

[10]  I. Petersen,et al.  Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome , 1997, Cancer.

[11]  K. Ault,et al.  Loss of heterozygosity in human ovarian cancer on chromosome 19q. , 1997, Gynecologic oncology.

[12]  E. Reed,et al.  Enhanced XPA mRNA levels in cisplatin-resistant human ovarian cancer are not associated with XPA mutations or gene amplification. , 1996, Cancer letters.

[13]  G. Gyapay,et al.  Characterization of regions of chromosomes 12 and 16 involved in nephroblastoma tumorigenesis , 1995, Genes, chromosomes & cancer.

[14]  I. Newsham,et al.  A constitutional bws‐related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in wilms' tumors , 1995, Genes, chromosomes & cancer.

[15]  K. Kinzler,et al.  Inactivation of both APC alleles in human and mouse tumors. , 1994, Cancer research.

[16]  E. Fearon,et al.  Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. , 1994, Cancer research.

[17]  T. Uchida,et al.  Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 genes in renal cell carcinoma. , 1994, Cancer research.

[18]  Bert Vogelstein,et al.  Hypermutability and mismatch repair deficiency in RER+ tumor cells , 1993, Cell.

[19]  D. Sidransky,et al.  Microsatellite instability in bladder cancer. , 1993, Cancer research.

[20]  S. Lerner,et al.  Role of chromosome 9 in human bladder cancer. , 1993, Cancer research.

[21]  J. Tomaszewski,et al.  Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. , 1993, Human molecular genetics.

[22]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[23]  Y. Nakamura,et al.  Multiple forms of the APC gene transcripts and their tissue-specific expression. , 1993, Human molecular genetics.

[24]  Shibo Li,et al.  Frequent loss of heterozygosity on chromosomes Xp and 13q in human ovarian cancer , 1992, International journal of cancer.

[25]  V. Bohr,et al.  ERCC1 and ERCC2 expression in malignant tissues from ovarian cancer patients. , 1992, Journal of the National Cancer Institute.

[26]  P. O'Connor,et al.  Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines , 1992, Molecular and cellular biology.

[27]  R. Wood,et al.  Proliferating cell nuclear antigen is required for DNA excision repair , 1992, Cell.

[28]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .